Total Payments
$13,362
2024 Payments
$1,738
Companies
45
Transactions
556
Medicare Patients
8,885
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$12,967 (97.0%)
Education$395.46 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,967 | 548 | 97.0% |
| Education | $395.46 | 8 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,942 | 89 | $0 (2024) |
| Amgen Inc. | $1,429 | 50 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,418 | 87 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $834.94 | 33 | $0 (2024) |
| Gilead Sciences, Inc. | $694.58 | 56 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $652.03 | 34 | $0 (2024) |
| Amarin Pharma Inc. | $550.44 | 24 | $0 (2022) |
| Merck Sharp & Dohme LLC | $532.91 | 18 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $462.17 | 9 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $383.97 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,738 | 29 | Kestra Medical Technology Services, Inc. ($374.27) |
| 2023 | $1,671 | 60 | Boehringer Ingelheim Pharmaceuticals, Inc. ($352.04) |
| 2022 | $1,775 | 93 | Janssen Pharmaceuticals, Inc ($389.38) |
| 2021 | $1,951 | 90 | Janssen Pharmaceuticals, Inc ($451.22) |
| 2020 | $1,085 | 53 | Amarin Pharma Inc. ($375.54) |
| 2019 | $1,062 | 54 | Novartis Pharmaceuticals Corporation ($274.34) |
| 2018 | $2,465 | 115 | Gilead Sciences, Inc. ($506.16) |
| 2017 | $1,614 | 62 | Novartis Pharmaceuticals Corporation ($299.03) |
All Payment Transactions
556 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $82.38 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/12/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.69 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: DIABETES | ||||||
| 08/30/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $37.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.61 | General |
| Category: Cardiovascular | ||||||
| 08/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $113.85 | General |
| Category: Obesity | ||||||
| 08/26/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $82.02 | General |
| Category: Cardiology | ||||||
| 08/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $26.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $137.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $45.31 | General |
| Category: Cardiology | ||||||
| 08/02/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $38.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/01/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/19/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Cardiology | ||||||
| 07/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $47.78 | General |
| Category: Cardiology | ||||||
| 07/12/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.05 | General |
| 07/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $114.08 | General |
| Category: Cardiovascular | ||||||
| 06/19/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $145.58 | General |
| Category: Cardiology | ||||||
| 06/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $39.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/03/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $53.58 | General |
| Category: Cardiology | ||||||
| 05/29/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/16/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $143.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/16/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.97 | General |
| Category: Cardiovascular | ||||||
| 05/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/26/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $143.02 | General |
| Category: Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,944 | 5,231 | $1.1M | $339,114 |
| 2022 | 26 | 1,865 | 5,468 | $1.2M | $361,830 |
| 2021 | 31 | 2,343 | 8,692 | $1.5M | $449,483 |
| 2020 | 33 | 2,733 | 9,224 | $1.7M | $513,116 |
Total Patients
8,885
Total Services
28,615
Medicare Billing
$1.7M
Procedure Codes
135
All Medicare Procedures & Services
135 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 339 | 874 | $279,680 | $80,086 | 28.6% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 50 | 50 | $188,150 | $58,876 | 31.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 246 | 246 | $121,032 | $35,470 | 29.3% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 50 | 100 | $99,800 | $31,984 | 32.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 124 | 174 | $78,996 | $21,208 | 26.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 137 | 211 | $54,227 | $20,315 | 37.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 115 | 123 | $61,031 | $17,254 | 28.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 83 | 83 | $39,508 | $11,317 | 28.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Office | 2023 | 14 | 14 | $37,618 | $11,219 | 29.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 56 | 224 | $33,152 | $10,190 | 30.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 95 | 144 | $25,776 | $9,167 | 35.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 50 | 50 | $27,950 | $7,953 | 28.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 83 | 84 | $14,816 | $4,503 | 30.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 61 | 61 | $10,736 | $3,317 | 30.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 17 | 17 | $10,217 | $3,171 | 31.0% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 22 | 22 | $10,274 | $3,170 | 30.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 171 | 189 | $6,804 | $2,055 | 30.2% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 22 | 22 | $5,346 | $1,683 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 20 | $4,540 | $1,070 | 23.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 24 | 26 | $3,276 | $1,006 | 30.7% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 19 | 19 | $3,515 | $951.23 | 27.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 11 | 11 | $2,134 | $667.26 | 31.3% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 17 | 18 | $1,566 | $464.65 | 29.7% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Office | 2023 | 22 | 22 | $1,386 | $429.66 | 31.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 49 | $735.00 | $411.60 | 56.0% |
About Dr. Milan Kothari, M.D
Dr. Milan Kothari, M.D is a Cardiovascular Disease healthcare provider based in Winter Park, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1740282037.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Milan Kothari, M.D has received a total of $13,362 in payments from pharmaceutical and medical device companies, with $1,738 received in 2024. These payments were reported across 556 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($12,967).
As a Medicare-enrolled provider, Kothari has provided services to 8,885 Medicare beneficiaries, totaling 28,615 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 135 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Nuclear Cardiology
- Location Winter Park, FL
- Active Since 06/01/2005
- Last Updated 07/20/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1740282037
Products in Payments
- XARELTO (Drug) $1,942
- Repatha (Biological) $1,353
- ENTRESTO (Drug) $1,312
- JARDIANCE (Drug) $781.62
- Vascepa (Drug) $550.44
- VERQUVO (Drug) $532.91
- LifeVest (Device) $383.97
- CAMZYOS (Drug) $381.22
- Assure WCD (Device) $374.27
- WATCHMAN (Device) $337.18
- Impella (Device) $286.28
- Rotarex (Device) $274.12
- ELIQUIS (Drug) $256.43
- PRALUENT (Drug) $249.13
- Ranexa (Drug) $245.64
- NORTHERA (Drug) $226.97
- NEXLETOL (Drug) $180.87
- OPTIMIZER (Device) $179.25
- FFRct (Device) $151.87
- CARDIOMEMS (Device) $143.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Winter Park
Dr. Usman Siddiqui, Md, MD
Cardiovascular Disease — Payments: $1.2M
Cardiovascular Disease $1.2M
Dr. Karan Reddy, M.d, M.D
Cardiovascular Disease — Payments: $41,494
Cardiovascular Disease $41,494
Dr. Sandeep Bajaj, M.d, M.D
Cardiovascular Disease — Payments: $15,332
Cardiovascular Disease $15,332
Barton Sickinger, Do Facc, DO FACC
Cardiovascular Disease — Payments: $12,968
Cardiovascular Disease $12,968
Dr. Kunal Teli, M.d, M.D
Cardiovascular Disease — Payments: $7,814
Cardiovascular Disease $7,814
Dr. Harish Patil, M.d, M.D
Cardiovascular Disease — Payments: $5,478
Cardiovascular Disease $5,478